脱パイロジェン滅菌空バイアルの市場規模、シェア、成長分析：製品タイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

脱パイロジェン滅菌空バイアル市場規模は2023年に39億米ドルと評価され、2024年の41億3,000万米ドルから2032年には65億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.9％で成長する見通しです。

脱パイロジェン滅菌空バイアルの世界市場は、製薬およびバイオテクノロジー分野における無菌包装の需要の高まりにより、大きな成長を遂げています。有害なパイロジェンを含まないように設計されたこれらのバイアルは、医薬品開発やワクチン製造が増加する中、医療製品の安全性と完全性を確保するために不可欠です。メーカーは、汚染リスクを最小限に抑えるため、品質コンプライアンスと技術革新に注力しています。さらに、ヘルスケア産業の拡大が市場の持続的成長の呼び水となっており、安全なドラッグストレージとデリバリーの重要性が浮き彫りになっています。持続可能性を重視する傾向が強まっていることも市場を形成しており、メーカーは製品の完全性を維持しながら二酸化炭素排出量を削減するため、環境に優しい包装ソリューションやエネルギー効率の高い生産方法を模索しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

脱パイロジェン滅菌空バイアル市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 5mL未満
• 5mL～20ml
• 20mL

脱パイロジェン滅菌空バイアル市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 臨床検査室
• 調合ラボ
• 製薬・バイオテクノロジー企業

脱パイロジェン滅菌空バイアル市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Schott AG（Germany）
• Gerresheimer AG（Germany）
• Stevanato Group（Italy）
• SGD Pharma（France）
• Nipro Corporation（Japan）
• West Pharmaceutical Services, Inc.（USA）
• Corning Incorporated（USA）
• DWK Life Sciences GmbH（Germany）
• Thermo Fisher Scientific Inc.（USA）
• SiO2 Materials Science（USA）
• Ompi（Italy）
• Piramal Glass（India）
• Stoelzle Glass Group（Austria）
• Amcor plc（Australia）
• AptarGroup, Inc.（USA）
• Bormioli Pharma（Italy）
• Daikyo Seiko, Ltd.（Japan）
• Vetter Pharma International GmbH（Germany）
• Adelphi Healthcare Packaging（UK）
• Pacific Vial Manufacturing Inc.（USA）

結論と提言

Depyrogenated Sterile Empty Vials Market size was valued at USD 3.9 billion in 2023 and is poised to grow from USD 4.13 billion in 2024 to USD 6.53 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2025-2032).

The global market for depyrogenated sterile empty vials is experiencing significant growth, driven by the escalating demand for aseptic packaging in the pharmaceutical and biotech sectors. These vials, designed to be free of harmful pyrogens, are essential for ensuring the safety and integrity of medical products amid increasing drug development and vaccine production. Manufacturers are focusing on quality compliance and technological innovations to minimize contamination risks. Additionally, the healthcare industry's expansion is priming the market for sustained growth, underscoring the importance of secure drug storage and delivery. A rising emphasis on sustainability is also shaping the market, with manufacturers exploring eco-friendly packaging solutions and energy-efficient production practices to reduce their carbon footprint while maintaining product integrity.

Top-down and bottom-up approaches were used to estimate and validate the size of the Depyrogenated Sterile Empty Vials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Depyrogenated Sterile Empty Vials Market Segments Analysis

Global Depyrogenated Sterile Empty Vials Market is segmented by Product Type, End User and region. Based on Product Type, the market is segmented into < 5 mL, 5 mL - 20ml and > 20 mL. Based on End User, the market is segmented into Clinical Labs, Compounding Labs and Pharma and Biotech Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Depyrogenated Sterile Empty Vials Market

The expansion of the pharmaceutical sector significantly fuels the need for depyrogenated sterile empty vials, which are essential for the packaging of injectable medications, vaccines, and other parenteral formulations. With the continuous growth and aging of the global population, there is an anticipated rise in the demand for pharmaceutical products, consequently elevating the need for corresponding packaging solutions. This trend underlines the vital role that depyrogenated sterile empty vials play in ensuring the safe and effective delivery of medical treatments, positioning them as a crucial element in the supply chain of the pharmaceutical industry.

Restraints in the Depyrogenated Sterile Empty Vials Market

The market for depyrogenated sterile empty vials faces certain challenges that could hinder its growth prospects. The intricate processes and rigorous quality control measures required for their production often lead to elevated manufacturing costs. Furthermore, the highly competitive landscape of the pharmaceutical sector can create significant pricing pressures, compelling manufacturers to lower their prices. This combination of increased production expenses and reduced profitability may pose substantial restraints on the overall growth of the depyrogenated sterile empty vials market, as manufacturers navigate the complexities of maintaining quality while remaining financially viable in a crowded marketplace.

Market Trends of the Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials market is experiencing significant growth, largely fueled by the expanding pharmaceutical industry. As research and development in pharmaceuticals intensify, there is a rising demand for packaging solutions that ensure drug safety and efficacy, particularly for injectables. This trend is further propelled by the increasing production of biologics, vaccines, and specialized medications, all of which necessitate stringent sterility standards in packaging. As businesses strive to meet regulatory compliance and consumer safety expectations, the market for these vials is positioned for continued expansion, reflecting a robust alignment with industry needs for advanced sterile packaging solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Depyrogenated Sterile Empty Vials Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• < 5 mL
• 5 mL - 20ml
• 20 mL

Global Depyrogenated Sterile Empty Vials Market Size by End User & CAGR (2025-2032)

• Market Overview
• Clinical Labs
• Compounding Labs
• Pharma and Biotech Companies

Global Depyrogenated Sterile Empty Vials Market Size & CAGR (2025-2032)

• North America (Product Type, End User)
  • US
  • Canada
• Europe (Product Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DWK Life Sciences GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SiO2 Materials Science (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Glass (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stoelzle Glass Group (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amcor plc (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bormioli Pharma (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daikyo Seiko, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adelphi Healthcare Packaging (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Vial Manufacturing Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations